Phenylephrine is an alpha-1 adrenergic receptor agonist used to treat hypotension, dilate the pupil, and induce local vasoconstriction. The action of phenylephrine, or neo-synephrine, was first described in literature in the 1930s.
Phenylephrine was granted FDA approval in 1939.
Phenylephrine is available in various drug formulations, which have different indications. Phenylephrine injections are indicated to treat hypotension caused by shock or anesthesia. The ophthalmic formulation is indicated to induce mydriasis and conjunctival vasoconstriction. The intranasal formulation is used to treat congestion, and a topical formulation ...
University of Alberta, Edmonton, Alberta, Canada
Yonsei University Health System, Severance Hospital, Seoul, Korea, Republic of
Tribhuvan university teaching hospital, Kathmandu, Bagmati, Nepal
UCSF Medical Center at Parnassus, San Francisco, California, United States
UCSF Medical Center at Mission Bay, San Francisco, California, United States
Ronald Reagan UCLA Medical Center, Los Angeles, California, United States
University Hospital Linköping, Linköping, Östergötland, Sweden
Thomas Jefferson Univesity, Philadelphia, Pennsylvania, United States
General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China
Montefiore Medical Center, New York, New York, United States
University of Missouri-Columbia, Columbia, Missouri, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.